ANL 31.55 Increased By ▲ 0.05 (0.16%)
ASC 20.80 Increased By ▲ 1.00 (5.05%)
ASL 24.00 Increased By ▲ 0.04 (0.17%)
BOP 8.17 Decreased By ▼ -0.10 (-1.21%)
BYCO 10.24 Decreased By ▼ -0.18 (-1.73%)
FCCL 22.60 Decreased By ▼ -0.13 (-0.57%)
FFBL 27.20 Increased By ▲ 0.10 (0.37%)
FFL 21.20 Increased By ▲ 0.80 (3.92%)
FNEL 9.18 Increased By ▲ 0.40 (4.56%)
GGGL 28.03 Decreased By ▼ -0.07 (-0.25%)
GGL 46.75 Increased By ▲ 0.20 (0.43%)
HUMNL 7.55 Increased By ▲ 0.20 (2.72%)
JSCL 22.93 Increased By ▲ 0.28 (1.24%)
KAPCO 40.10 Increased By ▲ 0.18 (0.45%)
KEL 3.94 Decreased By ▼ -0.04 (-1.01%)
MDTL 3.81 Increased By ▲ 0.06 (1.6%)
MLCF 45.10 Decreased By ▼ -0.65 (-1.42%)
NETSOL 167.35 Increased By ▲ 1.29 (0.78%)
PACE 8.03 Decreased By ▼ -0.12 (-1.47%)
PAEL 34.87 Increased By ▲ 0.42 (1.22%)
PIBTL 11.35 Decreased By ▼ -0.10 (-0.87%)
POWER 9.35 Decreased By ▼ -0.01 (-0.11%)
PRL 24.13 Increased By ▲ 0.24 (1%)
PTC 11.75 Decreased By ▼ -0.05 (-0.42%)
SILK 1.83 No Change ▼ 0.00 (0%)
SNGP 51.18 Decreased By ▼ -5.07 (-9.01%)
TELE 15.57 Increased By ▲ 0.82 (5.56%)
TRG 168.06 Increased By ▲ 0.80 (0.48%)
UNITY 43.84 Decreased By ▼ -0.36 (-0.81%)
WTL 3.82 Increased By ▲ 0.26 (7.3%)
BR100 5,176 Decreased By ▼ -28.35 (-0.54%)
BR30 26,711 Decreased By ▼ -45.55 (-0.17%)
KSE100 47,673 Decreased By ▼ -120.39 (-0.25%)
KSE30 19,107 Decreased By ▼ -54.37 (-0.28%)

Coronavirus
VERY HIGH Source: covid.gov.pk
Pakistan Deaths
23,048
3224hr
Pakistan Cases
1,008,446
3,75224hr
7.51% positivity
Sindh
367,092
Punjab
353,238
Balochistan
29,571
Islamabad
85,780
KPK
141,925
World

UK medicines regulator to hold press conference on AstraZeneca jab

  • EU countries have also detected dozens of cases of people with clots in blood vessels draining from the brain after receiving the vaccine.
07 Apr 2021

LONDON: Britain's independent medicines regulator said it will hold a press conference Wednesday afternoon over concerns about links between AstraZeneca's Covid-19 vaccine and blood clots.

The 3:00 pm (1400 GMT) press conference by officials from the MHRA regulator and the government's Joint Committee on Vaccination and Immunisation, comes as the European Medicines Agency will simultaneously present its findings on the issue.

The briefings follow around 30 blood clot incidents in Britain, including seven that proved fatal, involving people who had received the jab, the MHRA has said.

In total 18 million doses of the vaccine developed by the British-Swedish pharmaceutical company and Oxford University have been administered in the UK.

EU countries have also detected dozens of cases of people with clots in blood vessels draining from the brain after receiving the vaccine.

Oxford University said late on Tuesday that it had paused a British trial of the AstraZeneca vaccine on children pending a decision by the MHRA.

In recent weeks, as questions were raised by several European nations over possible links between the AstraZeneca vaccine and blood clots, the UK has defended its homegrown jab.

As a precautionary measure several countries have stopped administering the AstraZeneca vaccine within certain age groups and at different points nations including France, Germany, Norway and Denmark have suspended its deployment.

Vaccine hesitancy related to fears about the AstraZeneca jab could hamper Britain's mass vaccination programme.

More than 31.6 million first doses of either the AstraZeneca or Pfizer vaccines have been given out, representing three out of every five adults.